BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//OMTEC - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:OMTEC
X-ORIGINAL-URL:https://omtecexpo.com
X-WR-CALDESC:Events for OMTEC
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20250101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20260609T130000
DTEND;TZID=UTC:20260609T134500
DTSTAMP:20260603T225056
CREATED:20260216T152825Z
LAST-MODIFIED:20260430T165228Z
UID:10000080-1781010000-1781012700@omtecexpo.com
SUMMARY:DFM Essentials: Reducing Risk and Cost in Medical Device Development
DESCRIPTION:Design for Manufacturability (DFM) is critical to accelerating product timelines\, ensuring quality\, and minimizing costly redesigns. In this session\, orthopedic engineers will learn how to apply DFM principles early and effectively — from concept through validation and transfer to manufacturing. OEMs and CMs engineering leaders will share proven methods for identifying and eliminating design inefficiencies\, collaborating with suppliers to improve component manufacturability\, and balancing performance with production realities. Attendees will leave with practical tools to reduce risk\, control costs\, and build more reliable medical devices that scale seamlessly from prototype to production. \nSession speakers represent Stryker\, Medtronic and Resonetics. \nKey Takeaways\n1. Dos and don’ts for successful DFM processes from tenured engineering leaders.\n2. Learn how to reduce variability throughout the design and manufacturing process.\n3. Understand how to incorporate design with regulatory\, manufacturing scale and margin needs. \n>> This session is part 1 of OMTEC’s 3-part R&D Symposium held from 1:00 p.m.-4:00 p.m. Don’t miss the two other sessions.\nAI-Powered R&D: Turning Data into a Competitive Advantage\nNavigating the Complexity of Today’s R&D Teams
URL:https://omtecexpo.com/session/dfm-essentials-reducing-risk-and-cost-in-medical-device-development/
ATTACH;FMTTYPE=image/jpeg:https://omtecexpo.com/wp-content/uploads/2026/02/Design-for-Manufacturability.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260609T130000
DTEND;TZID=UTC:20260609T141500
DTSTAMP:20260603T225056
CREATED:20260212T164007Z
LAST-MODIFIED:20260514T203737Z
UID:10000077-1781010000-1781014500@omtecexpo.com
SUMMARY:What Great Negotiators Do Differently
DESCRIPTION:Effective negotiation sits at the core of every successful supply chain partnership. This engaging\, interactive session equips procurement professionals with practical tools and proven frameworks to secure value\, manage risk\, and strengthen supplier relationships.\nParticipants will explore the top business challenges shaping today’s supply chain relationships and learn how to plan strategically before diving into a hands-on negotiation exercise led by a sourcing expert turned negotiation trainer. \nOEMs and suppliers will leave this session with actionable insights into key negotiation principles\, including positioning and anchoring\, setting high aspirations\, managing information effectively\, distinguishing between needs and wants\, understanding individual power\, and concessioning strategically. \nKey Takeaways \n1. Understand different frameworks for negotiating supplier contracts.\n2. Spend time planning\, practicing and honing negotiation skills during this session.\n3. Learn proven principles for setting goals and communicating effectively. \n>> This session is part 1 of OMTEC’s 3-part Supply Chain Symposium held from 1:00 p.m.-4:00 p.m. Don’t miss the two other sessions.\nFrom Compliance to Continuity: Using AI to Predict & Prevent Supplier Risk\nNavigating Today’s Global Supply Chain \n 
URL:https://omtecexpo.com/session/what-great-negotiators-do-differently/
ATTACH;FMTTYPE=image/jpeg:https://omtecexpo.com/wp-content/uploads/2026/02/Supply-Chain-Negotiations.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260609T140000
DTEND;TZID=UTC:20260609T144500
DTSTAMP:20260603T225056
CREATED:20260216T152733Z
LAST-MODIFIED:20260430T165238Z
UID:10000081-1781013600-1781016300@omtecexpo.com
SUMMARY:AI-Powered R&D: Turning Data into a Competitive Advantage
DESCRIPTION:AI is rapidly transforming how R&D teams design\, test and validate new orthopedic devices. This session explores ways that leading organizations are integrating AI into their R&D workflows to accelerate innovation\, optimize design decisions and uncover insights that lead to enhanced products and improved patient outcomes. The speakers will share practical examples of AI applications in materials selection\, simulation and design optimization\, as well as lessons learned in managing data quality\, cross-functional collaboration\, and regulatory and quality considerations. Attendees will leave with a clear understanding of how AI can strengthen engineering decision-making and turn data into a lasting competitive advantage. \nKey Takeaways\n1. Discover where AI delivers the most impact for R&D teams.\n2. Learn how to strengthen engineering decisions with data and smarter workflows.\n3. Understand how the right systems can be used as a competitive advantage. \n>> This session is part 2 of OMTEC’s 3-part R&D Symposium held from 1:00 p.m.-4:00 p.m. Don’t miss the two other sessions.\nDFM Essentials: Reducing Risk and Cost in Medical Device Development\nNavigating the Complexity of Today’s R&D Team
URL:https://omtecexpo.com/session/ai-powered-rd-turning-data-into-a-competitive-advantage/
ATTACH;FMTTYPE=image/jpeg:https://omtecexpo.com/wp-content/uploads/2026/02/AI-Research-and-Development.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260609T143000
DTEND;TZID=UTC:20260609T150000
DTSTAMP:20260603T225056
CREATED:20260216T162805Z
LAST-MODIFIED:20260430T165131Z
UID:10000083-1781015400-1781017200@omtecexpo.com
SUMMARY:From Compliance to Continuity: Using AI to Predict & Prevent Supplier Risk
DESCRIPTION:For a supply chain leader\, a quality finding isn’t just a compliance headache—it is a leading indicator of a future backorder. Yet\, most orthopedic companies still rely on snapshot audits conducted once every two years\, leaving them blind to vendor health for the other 729 days. In a fragile global market\, this lack of visibility is a strategic vulnerability. \nThis session introduces Audit Intelligence\, a new framework that bridges the gap between quality and supply chain. Attendees will learn how to use AI to continuously analyze supplier documentation\, turning static audit reports into dynamic risk signals. We will move beyond the “checklist” mentality to a predictive model that ensures supply continuity and regulatory readiness. \nKey Takeaways \n1. The Framework: A practical roadmap for integrating AI into supply chain workflows to predict vendor failure before it happens.\n2. The Tools: New methods for uncovering hidden supply chain vulnerabilities that manual audits miss.\n3. The Regulatory Shift: How the current regulatory environment is forcing a transition from “compliance” to “risk management.” \n>> This session is part 2 of OMTEC’s 3-part Supply Chain Symposium held from 1:00 p.m.-4:00 p.m. Don’t miss the two other sessions.\nWhat Great Negotiators Do Differently\nNavigating Today’s Global Supply Chain \n 
URL:https://omtecexpo.com/session/implementing-ai-to-predict-and-prevent-supplier-risk/
ATTACH;FMTTYPE=image/jpeg:https://omtecexpo.com/wp-content/uploads/2026/02/AI-In-Supply-Chain-Audit.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260609T151500
DTEND;TZID=UTC:20260609T160000
DTSTAMP:20260603T225056
CREATED:20260212T170217Z
LAST-MODIFIED:20260430T180317Z
UID:10000078-1781018100-1781020800@omtecexpo.com
SUMMARY:Navigating Today’s Global Supply Chain
DESCRIPTION:Evolving tariff policies\, geopolitical uncertainty\, and inflationary pressures continue to challenge even the most resilient supply chains. This panel discussion examines how orthopedic device manufacturers and suppliers can adapt their sourcing\, logistics\, and pricing strategies to remain competitive in today’s environment. Through real-world examples and strategic insights\, including lessons learned from onshoring and regionalization efforts\, attendees will gain practical guidance to help their supply chain teams strengthen resilience\, protect margins\, and maintain business continuity in an evolving environment. \nSession speakers represent Skeletal Dynamics\, Smith+Nephew\, Carpenter Technology and HG Medical. \nKey Takeaways\n1. Understand how tariffs and inflation are shaping supply chain economics.\n2. Learn practical sourcing and logistics strategies to reduce risk and improve agility.\n3. Identify cost management approaches to protect margins while maintaining supplier relationships. \n>> This session is part 3 of OMTEC’s 3-part Supply Chain Symposium held from 1:00 p.m.-4:00 p.m. Don’t miss the two other sessions.\nWhat Great Negotiators Do Differently\nFrom Compliance to Continuity: Using AI to Predict & Prevent Supplier Risk
URL:https://omtecexpo.com/session/navigating-todays-global-supply-chain/
ATTACH;FMTTYPE=image/jpeg:https://omtecexpo.com/wp-content/uploads/2026/02/Navigating-Todays-Supply-Chain.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260609T151500
DTEND;TZID=UTC:20260609T160000
DTSTAMP:20260603T225056
CREATED:20260216T152632Z
LAST-MODIFIED:20260430T165301Z
UID:10000082-1781018100-1781020800@omtecexpo.com
SUMMARY:Navigating the Complexity of Today’s R&D Teams
DESCRIPTION:Orthopedic R&D is more intricate than ever\, blending diverse disciplines\, dispersed teams\, rapid technology change and business acumen. This panel discussion explores the pressing challenges engineering teams face and offers practical strategies for leading and collaborating effectively in sophisticated environments. R&D leaders with extensive OEM experience will share advice on navigating advanced technology\, collaboration with external design teams\, and simply doing more with less. Panelists will share advice on ways to foster cross-functional communication and build resilience in dynamic\, innovation-driven organizations. \nSession speakers represent Smith+Nephew\, Exalta and Human Aided Design. \nKey Takeaways\n1. Understand the biggest challenges facing R&D teams today.\n2. Learn practical strategies to strengthen internal and external cross-functional communication and work.\n3. Gain insight into how to build resilient\, high-performing teams. \n>> This session is part 3 of OMTEC’s 3-part R&D Symposium held from 1:00 p.m.-4:00 p.m. Don’t miss the two other sessions.\nDFM Essentials: Reducing Risk and Cost in Medical Device Development\nAI-Powered R&D: Turning Data into a Competitive Advantage\n \n 
URL:https://omtecexpo.com/session/navigating-the-complexity-of-todays-rd-teams/
ATTACH;FMTTYPE=image/png:https://omtecexpo.com/wp-content/uploads/2026/02/Navigating-RD-Teams.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260610T080000
DTEND;TZID=UTC:20260610T093000
DTSTAMP:20260603T225056
CREATED:20260202T224323Z
LAST-MODIFIED:20260212T155907Z
UID:10000070-1781078400-1781083800@omtecexpo.com
SUMMARY:The Innovation Imperative: Preparing for the Next Chapter in Orthopedics
DESCRIPTION:The orthopedic industry is entering a new era defined by intelligent systems\, precision engineering and data-driven care. Enabling technologies are expanding the surgeon’s capabilities with unprecedented accuracy\, reproducibility and intraoperative consistency. At the same time\, digital healthcare and connected platforms are transforming the ways procedures are planned and personalized\, unlocking predictive insights and clinical decision support that elevate patient outcomes. Additive manufacturing continues to drive innovation in implant and instrument design\, enabling patient-matched solutions\, complex geometries\, enhanced surface technologies and rapid iteration cycles. \nRobert Cohen\, Vice President of Innovation and Technology at Stryker\, will explore how the convergence of these technologies is redefining what’s possible across orthopedic engineering\, digital and artificial intelligence\, manufacturing\, operations and\, most importantly\, patient care. The next decade will be led by orthopedic OEMs\, suppliers and service providers who embrace this merging by leveraging digital tools\, advanced materials\, sophisticated manufacturing and intelligent automation to deliver more efficient and effective procedures\, differentiated implants\, enabling technologies and increasingly personalized patient experiences. \nSchedule: \n\nHot buffet breakfast served at 8 a.m.\nOMTEC Excellence Awards Ceremony at 8:30 a.m.\nKeynote at 8:45 a.m.
URL:https://omtecexpo.com/session/the-innovation-imperative-preparing-for-the-next-chapter-in-orthopedics/
ATTACH;FMTTYPE=image/jpeg:https://omtecexpo.com/wp-content/uploads/2026/02/OMTEC-2026-Keynote.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260610T095000
DTEND;TZID=UTC:20260610T100500
DTSTAMP:20260603T225056
CREATED:20260318T120444Z
LAST-MODIFIED:20260318T123915Z
UID:10000085-1781085000-1781085900@omtecexpo.com
SUMMARY:The Role of Automation and AI in High-Mix Low-Volume Manufacturing
DESCRIPTION:The medical manufacturing industry is defined by constant innovation and high-level competition. As quality and delivery standards continue to rise each year\, high-mix/low-volume manufacturers must adopt new technologies to stay ahead of the curve. Since 2023\, Arcamed’s investments in automation and AI have reduced costs by 25% while maintaining consistent order completion rates. Automation has established consistent procedures\, allowing 8-week lead times at 98.8% on time delivery\, 97.7% on time in full\, and 97.7% orders defect-free. This has enabled Arcamed to cultivate a reputation as an industry leader in speed\, quality\, and cost. This presentation will explore the strategic investments in technology that have enabled a greater state of control and visibility of capacity\, supply chain\, and delivery\, offering practical insights into the successful navigation and implementation of new technology. \nAttend this presentation by Arcamed in Booth 1160.
URL:https://omtecexpo.com/session/the-role-of-automation-and-ai-in-high-mix-low-volume-manufacturing/
ATTACH;FMTTYPE=image/jpeg:https://omtecexpo.com/wp-content/uploads/2026/03/Manufacturing-Automation.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260610T101000
DTEND;TZID=UTC:20260610T102500
DTSTAMP:20260603T225056
CREATED:20260318T120436Z
LAST-MODIFIED:20260318T123250Z
UID:10000086-1781086200-1781087100@omtecexpo.com
SUMMARY:From Concept to Reality: Multi-Metal 3D Printing for Orthopedic Implants
DESCRIPTION:What if orthopedic engineers could position each metal exactly where its properties matter most? Multi-metal 3D printing is bringing this concept into practical reach. This presentation explains the process architecture that enables the integration of multiple alloys within a single component\, and highlights the key developments required to move from early exploration to stable and reproducible results. \nAttendees will gain insight into achievable material combinations\, interface geometries\, bonding mechanisms\, and the mechanical performance of multi-metal joints. The session also shows how engineered transitions create design freedoms and enable applications that cannot be realized with single alloy 3D printing. \nAs the first commercial group advancing this technology\, we will share unique findings and representative examples\, including multi-metal orthopedic applications that demonstrate current capabilities and emerging potential. \nAttend this session by Amnovis in Booth 1332.
URL:https://omtecexpo.com/session/from-concept-to-reality-multi-metal-3d-printing-for-orthopedic-implants/
ATTACH;FMTTYPE=image/jpeg:https://omtecexpo.com/wp-content/uploads/2026/03/Multi-Metal-3D-Printing-Amnovis.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260610T103000
DTEND;TZID=UTC:20260610T104500
DTSTAMP:20260603T225056
CREATED:20260318T120455Z
LAST-MODIFIED:20260602T204820Z
UID:10000087-1781087400-1781088300@omtecexpo.com
SUMMARY:Designing Sterile Packaging for Patient Safety and Enhanced User Experience
DESCRIPTION:De-risking sterile packaging ecosystems for orthopedics demands special considerations. Maintaining sterile barrier protection is crucial\, yet risk escalates with sharp geometries\, high-mass devices\, and multi-component workflows. With packaging design impacting experience\, performance and safety\, early exploration is essential for differentiation and speed. \nThis session outlines a proven\, accelerated approach\, combining design research methodologies\, Human Factors insights and FEA to understand real‑world use\, remove risk early and reduce time to commercialization. Drawing on a high‑pressure program delivered for a global healthcare leader\, we show how to move from discovery to design freeze in just eight months. \nLearn how: early user insights prevent late‑stage sterile barrier failures; FEA can replace iterative physical testing; ecosystem‑level thinking supports smoother NPIs and transfers; early packaging exploration drives efficiency; and how to align diverse teams. \nAttend this session by Ensera in Booth 1104.
URL:https://omtecexpo.com/session/designing-sterile-packaging-for-patient-safety-and-enhanced-user-experience/
ATTACH;FMTTYPE=image/png:https://omtecexpo.com/wp-content/uploads/2026/03/Medical-Device-Packaging-Ensera.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260610T105000
DTEND;TZID=UTC:20260610T110500
DTSTAMP:20260603T225056
CREATED:20260318T120450Z
LAST-MODIFIED:20260318T123157Z
UID:10000088-1781088600-1781089500@omtecexpo.com
SUMMARY:Can Titanium Replace Cobalt Chrome? HIP-Nitriding Breakthrough
DESCRIPTION:With critical biocompatibility and sustainability challenges in load-bearing implants\, OEMs are seeking alternatives to cobalt chrome. Titanium offers a real alternative if its wear resistance can be solved. This presentation reveals how nitrogen-enhanced HIP cycles create protective TiN surface layers with roughly double titanium’s hardness and minimal measurable wear in pin-on-disc testing. \nCroom Medical\, Quintus Technologies\, and Uppsala University tested multiple HIP atmospheres on L-PBF Ti6Al4V\, with treated samples showing no delamination or coating failure — common challenges with PVD and plasma nitriding. The technique integrates surface hardening into the densification cycle\, eliminating separate coating operations. Attendees will learn which nitrogen concentrations and thermal profiles deliver optimal wear performance\, how to preserve nitride layers through post-processing\, and considerations for using AM titanium in articulating surfaces traditionally dominated by CoCrMo. \nAttend this session by Croom Medical in Booth 700.
URL:https://omtecexpo.com/session/can-titanium-replace-cobalt-chrome-hip-nitriding-breakthrough/
ATTACH;FMTTYPE=image/png:https://omtecexpo.com/wp-content/uploads/2026/03/Titanium-in-Medical-Devices.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260610T111500
DTEND;TZID=UTC:20260610T120000
DTSTAMP:20260603T225056
CREATED:20260212T135300Z
LAST-MODIFIED:20260323T140508Z
UID:10000072-1781090100-1781092800@omtecexpo.com
SUMMARY:Challenges and Opportunities in Designing Enabling Tech Instrumentation
DESCRIPTION:Enabling technologies are redefining the competitive landscape in orthopedic surgery but also place high demands on the engineers who must create components with tight tolerances needed for pinpoint accuracy. In this session\, learn how OEM and supplier teams collaborate early in the design process to complete prototyping cycles and comprehensive testing of planned parts\, and work together to find an effective balance between manufacturability and speed-to-market. \nThe expert panelists will discuss how process validation has become a major bottleneck in development and what can be done to effectively manage the process. Whether you’re building robotic-assisted\, navigation or implant positioning systems\, you’ll head home from this session with a clear idea of what it takes to build instrumentation for enabling technologies of the future. \nSession speakers represent OrthAlign\, Smith+Nephew and Elos Medtech. \nKey Takeaways\n1. Understand the complexities of designing and manufacturing enabling technology components.\n2. Learn strategies to balance manufacturability with speed-to-market.\n3. Hear how leaders in the space have overcome development and manufacturing bottlenecks.
URL:https://omtecexpo.com/session/challenges-and-opportunities-in-designing-enabling-tech-instrumentation/
ATTACH;FMTTYPE=image/jpeg:https://omtecexpo.com/wp-content/uploads/2026/02/Enabling-Technology-Instrumentation.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260610T111500
DTEND;TZID=UTC:20260610T120000
DTSTAMP:20260603T225056
CREATED:20260212T163238Z
LAST-MODIFIED:20260507T211957Z
UID:10000076-1781090100-1781092800@omtecexpo.com
SUMMARY:How to Turn Supplier Relationships into Strategic Partnerships
DESCRIPTION:OEMs and CMOs that communicate effectively and align shared values can accelerate orthopedic innovation and product development timelines. Developing working relationships based on consistently meeting expectations and shared problem-solving creates trust and teamwork that foster close-knit collaboration. Medtronic and OSSTEC\, along with their partner\, Lincotek Medical\, will provide attendees with practical advice on developing outsourcing deals based on transparency\, clearly defined goals\, and mutual interest in long-term growth. \nSession speakers include OSSTEC\, Medtronic and Lincotek Medical. \nKey Takeaways\n1. Understand how strong OEM-CMO alignment accelerates product development.\n2. Learn practical strategies for structuring outsourcing partnerships\, whether a startup or established company.\n3. Gain real-world perspective into building long-term relationships to leverage supply chain partners’ capabilities.
URL:https://omtecexpo.com/session/how-to-turn-supplier-relationships-into-strategic-partnerships/
ATTACH;FMTTYPE=image/jpeg:https://omtecexpo.com/wp-content/uploads/2026/02/Building-Supply-Chain-Relationships.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260610T134500
DTEND;TZID=UTC:20260610T143000
DTSTAMP:20260603T225056
CREATED:20260212T155709Z
LAST-MODIFIED:20260520T191844Z
UID:10000073-1781099100-1781101800@omtecexpo.com
SUMMARY:Infection Prevention is the Next Big Step in Orthopedic Devices
DESCRIPTION:Post-surgical infections are among the most devastating and costly complications in orthopedics\, a harsh reality that has increased interest in antimicrobial implant surface technologies\, which are emerging as a critical line of defense against infection and a primary focus of implant manufacturers. Learn from OEM implant engineers about how coatings and materials are designed to kill bacteria on contact\, prevent biofilm formation and protect against implant-related infections. The speakers will discuss the efficacy of technologies that are applied during the manufacturing process and address the R&D and regulatory challenges of scaling complex surface treatments for commercial use. \nSession speakers include Onkos Surgical\, Zimmer Biomet and Elos Medtech. \nKey Takeaways\n1. Gain insight into the new R&D focused on antimicrobial surface technologies.\n2. Understand the regulatory barriers to getting these technologies to market.\n3. Hear OEM and surgeon perspectives on why companies should prioritize infection prevention R&D efforts.
URL:https://omtecexpo.com/session/infection-prevention-is-the-next-big-step-in-orthopedic-devices/
ATTACH;FMTTYPE=image/jpeg:https://omtecexpo.com/wp-content/uploads/2026/02/Orthopedic-Infections.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260610T134500
DTEND;TZID=UTC:20260610T143000
DTSTAMP:20260603T225056
CREATED:20260212T162037Z
LAST-MODIFIED:20260602T020605Z
UID:10000075-1781099100-1781101800@omtecexpo.com
SUMMARY:How High-tech Tools are Used to Speed Time to Market
DESCRIPTION:Computational modeling and simulation (CM&S) allows engineers to assess device design performance\, optimize materials selection and analyze sterilization methods without the need for physical prototypes. By leveraging advanced simulation tools and techniques\, orthopedic companies can innovate more efficiently to commercialize high-quality devices faster and at a lower cost. Experts share real-world examples of how CM&S reduces development expenses\, shortens validation cycles and supports regulatory submissions with data-driven evidence. Attendees will learn how to integrate CM&S early in the design process to achieve faster iteration and speed the time to market.\n\nKey Takeaways\n1. Learn how CM&S drives design and development optimization for orthopedic devices.\n2. Gain knowledge of the latest tools engineers can implement during the R&D process.\n3. Understand how CM&S can support quality and regulatory documentation.
URL:https://omtecexpo.com/session/how-high-tech-tools-are-used-to-speed-time-to-market/
ATTACH;FMTTYPE=image/jpeg:https://omtecexpo.com/wp-content/uploads/2026/02/Speed-Time-to-Market.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260610T134500
DTEND;TZID=UTC:20260610T143000
DTSTAMP:20260603T225056
CREATED:20260407T200803Z
LAST-MODIFIED:20260409T171823Z
UID:10000100-1781099100-1781101800@omtecexpo.com
SUMMARY:Digital Transformation: Building Smarter\, More Resilient Products and Operations
DESCRIPTION:As complexity accelerates across orthopedic product development and supply chains\, leading organizations are shifting from fragmented\, static approaches to data-driven frameworks that improve visibility\, reduce risk\, and enable proactive decision-making. Through commercialized products and internal processes\, orthopedic companies seek to leverage the speed and flexibility of digital ecosystems that can scale efficiently\, respond faster\, and operate with greater confidence. But how should companies adopt these cutting-edge technologies\, and what risk mitigation measures need to be put into place? \nAttendees of this session will hear presentations from companies with expertise in AI\, connected medical devices\, and cybersecurity. \nBeyond the eQMS: The Rise of Audit Intelligence\nMonica Burt & Associates \nFor decades\, the medical device industry has digitized everything—except the audit. We moved SOPs to the cloud\, yet our most critical risk-sensing mechanism remains analog: one human\, one checklist\, one subjective opinion. This creates an “Intelligence Gap.” Your eQMS stores data but doesn’t understand it. It cannot read thousands of pages of supplier documentation to predict risk or normalize findings across global sites.\n\nIn this session\, Monica Burt introduces Audit Intelligence—the next evolution of quality. Unlike tools that simply digitize the clipboard\, Audit Intelligence uses NLP to ingest and analyze unstructured quality data at scale.\n\nAttendees will learn:\n•The Evolution: Why the “Digital Checklist” was only a half-step\n•The Mechanics: How AI maps text to ISO 13485 clauses to identify risk without bias\n•The New Standard: Moving from reactive auditing to predictive monitoring\n\nJoin us to see why the future isn’t gathering more data — it’s understanding the data you already have\n\nSecurity You Can Prove: Reducing Risk in Medical Device Innovation\nDornerWorks \nMedical devices are more connected\, software-driven\, and exposed than ever\, with risks of failure\, breaches\, and unintended behavior rising. As attack surfaces grow\, traditional “patch-and-protect” approaches to safety and cybersecurity are falling short. A new generation of provably correct system architectures embeds safety and security into the foundation of device operation\, ensuring systems behave as intended under fault or attack. By leveraging formally verified components and memory-safe software practices\, organizations can achieve guarantees of correct behavior\, including robust process isolation and elimination of entire classes of software defects. Beyond stronger security\, these approaches reduce maintenance burden by minimizing latent bugs and simplifying updates over the device lifecycle. This session explores how provable security reduces development risk\, accelerates time to market\, lowers long-term cost\, and increases confidence in next-generation medical systems.\n \nUnderstanding a Medical Device Cyber Attack: An Inside Look\nPlante Moran \nManufacturing companies face a unique cybersecurity threat landscape due to the convergence of modern enterprise networks and connected OT (Operational Technology) and IoT (Internet of Things) devices\, such as medical devices. This convergence expands the attack surface and allows cyber incidents to move from network systems into production environments and devices\, potentially causing downtime or safety risks. \n\nAttackers rarely focus on a medical device alone. Instead\, they take advantage of weaknesses in the surrounding hospital or manufacturing environment — such as poor network segmentation\, legacy systems\, weak credentials\, or insecure remote access. Once inside the environment\, they may monitor activity\, disrupt operations\, or compromise device behavior and data. This presentation illustrates a typical attack path and highlights the types of vulnerabilities that can be exploited to demonstrate the associated risks\, as well as\, best practices to mitigate these risks.
URL:https://omtecexpo.com/session/digital-transformation-building-smarter-products-and-operations/
ATTACH;FMTTYPE=image/jpeg:https://omtecexpo.com/wp-content/uploads/2026/04/digital-transformation.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260610T144500
DTEND;TZID=UTC:20260610T150000
DTSTAMP:20260603T225056
CREATED:20260318T120423Z
LAST-MODIFIED:20260318T172137Z
UID:10000090-1781102700-1781103600@omtecexpo.com
SUMMARY:Medical Device Integrated Hybrid Manufacturing
DESCRIPTION:Combining metal additive manufacturing (AM) and CNC machining is a proven industrial workflow for orthopedic\, dental\, and custom-made medical devices\, enabling complex geometries and high functional integration. \nThe next level of performance is now achieved through the integration of Hybrid Manufacturing into an end-to-end process that directly interconnects AM and precision machining. The key differentiator is the ability to CNC machine parts directly on the build plate or through advanced fixturing\, ensuring dimensional accuracy\, consistency\, and robust process. \nSuccessful implementation requires deep expertise in deformation-free printing\, optimal part positioning\, tailored heat treatment\, and precise coordinate transfer between additive and subtractive steps. Building on a robust AM experience\, the Swiss m4m Center will showcase hybrid manufacturing workflows that reduce lead time\, lower the cost of quality\, and unlock new potential for innovative medical devices. \nAttend this session by Swiss m4m Center in Booth 328.
URL:https://omtecexpo.com/session/medical-device-integrated-hybrid-manufacturing/
ATTACH;FMTTYPE=image/jpeg:https://omtecexpo.com/wp-content/uploads/2026/03/additive-manufacturing-machine.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260610T144500
DTEND;TZID=UTC:20260610T150000
DTSTAMP:20260603T225056
CREATED:20260318T120429Z
LAST-MODIFIED:20260318T123052Z
UID:10000089-1781102700-1781103600@omtecexpo.com
SUMMARY:Standardization in Cleaning: Why “Same Process” Doesn’t Mean “Same Result”
DESCRIPTION:As orthopedic manufacturing becomes increasingly distributed across multiple sites and suppliers\, organizations often pursue cleaning standardization to reduce risk and simplify validation. This is commonly done by transferring identical work instructions\, cycle parameters\, and acceptance criteria. Despite these efforts\, inconsistent cleanliness results and validation failures continue to be an issue. \nThis presentation examines why documented process equivalence often fails to produce equivalent outcomes. We highlight undervalued variables such as load configuration\, recipe management\, and human error. Common misconceptions surrounding validation transfer are discussed\, including treating validation as a portable recipe rather than a copy of a specific process configuration. We focus on an outcome-based approach in order to improve successful validation transfers and better align expectations around cleaning outcomes rather than standardization and documentation alone. \nAttend this session by Ecoclean in Booth 1323.
URL:https://omtecexpo.com/session/standardization-in-cleaning-why-same-process-doesnt-mean-same-result/
ATTACH;FMTTYPE=image/png:https://omtecexpo.com/wp-content/uploads/2026/03/Sterilization-Cleaning-Implants-and-Instruments.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260610T150500
DTEND;TZID=UTC:20260610T152000
DTSTAMP:20260603T225056
CREATED:20260318T120416Z
LAST-MODIFIED:20260318T123029Z
UID:10000091-1781103900-1781104800@omtecexpo.com
SUMMARY:Binder Jetting 17-4 SS: Rethinking Cost\, Speed\, and Instrument Design
DESCRIPTION:Medical instruments are critical to surgical success\, yet are often developed under severe time and cost pressure from late-stage implant design changes. As implants finalize near launch\, instrument sets often require redesign and rapid production\, leading to complex manufacturing\, long lead times\, and high launch costs that strain the orthopedic device supply chain. \nThis presentation shows how binder jetting of 17-4 provides a practical solution. By decoupling geometric complexity from manufacturing cost\, it enables design freedom to improve ergonomics and surgical workflow while maintaining scalability. Lincotek’s production process achieves H900 properties with excellent machinability for precision interfaces. Compared with conventional manufacturing\, binder-jet instruments can reduce cost and lead time by up to 50% and weight by ~15%. \nAttendees will learn design\, post-processing\, and implementation strategies enabling faster launches and more resilient instrument programs. \nAttend this session by Lincotek Medical in Booth 939.
URL:https://omtecexpo.com/session/binder-jetting-17-4-ss-rethinking-cost-speed-and-instrument-design/
ATTACH;FMTTYPE=image/jpeg:https://omtecexpo.com/wp-content/uploads/2026/03/Binder-Jetting-Lincotek-Medical.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260610T152500
DTEND;TZID=UTC:20260610T154000
DTSTAMP:20260603T225056
CREATED:20260318T120410Z
LAST-MODIFIED:20260318T123009Z
UID:10000092-1781105100-1781106000@omtecexpo.com
SUMMARY:Beyond Gamma: The Future of Radiation Sterilization for Orthopedics
DESCRIPTION:The orthopedic industry is undergoing significant change in the sterilization of implants and instruments. This session will provide an overview of electron beam and X-ray sterilization modalities; specifically\, how they compare to gamma and instructions for how to switch between these modalities for sterilization\, as well as microbiological and dose mapping considerations. We will also review how e-beam can effectively be used for orthopedics\, along with why X-ray is the future\, what those sterilization efforts look like\, and how the industry will make the shift. \nAttend this session by Steri-Tek in Booth 219.
URL:https://omtecexpo.com/session/beyond-gamma-the-future-of-radiation-sterilization-for-orthopedics/
ATTACH;FMTTYPE=image/jpeg:https://omtecexpo.com/wp-content/uploads/2026/03/Sterilization-Efforts-Medical-Device.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260610T154500
DTEND;TZID=UTC:20260610T160000
DTSTAMP:20260603T225056
CREATED:20260318T120353Z
LAST-MODIFIED:20260318T122948Z
UID:10000094-1781106300-1781107200@omtecexpo.com
SUMMARY:Residual Stress: A Hidden Source of Risk in Orthopedic Components
DESCRIPTION:Residual stress is a hidden cost in orthopedic components\, presenting itself as machining distortion\, variable tool life\, scrap\, rework\, and reduced reliability across the supply chain. This presentation explains where residual stress is introduced throughout the material lifecycle\, from the melt shop through metal manufacturing\, heat treatment\, and component machining. Attendees will learn practical indicators that help identify process‑driven distortion and recognize potential risks earlier in the supply chain. We will highlight recent developments in material production that reduce distortion while maintaining critical mechanical properties and corrosion resistance. A key focus is the introduction of Controlled Residual Stress 17‑4 stainless steel\, engineered to support more predictable machining\, improved dimensional stability\, and consistent conformance to demanding specifications—ultimately strengthening reliability of supply to valued customers. \nAttend this session by Carpenter Technology in Booth 1111.
URL:https://omtecexpo.com/session/residual-stress-a-hidden-source-of-risk-in-orthopedic-components/
ATTACH;FMTTYPE=image/jpeg:https://omtecexpo.com/wp-content/uploads/2026/03/residual-stress-in-steel-materials.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260610T154500
DTEND;TZID=UTC:20260610T160000
DTSTAMP:20260603T225056
CREATED:20260318T120359Z
LAST-MODIFIED:20260318T122927Z
UID:10000093-1781106300-1781107200@omtecexpo.com
SUMMARY:Dedicated Cellular Manufacturing: Next-Generation End-to-End Manufacturing
DESCRIPTION:In a landscape of supplier consolidation and volatile demand\, Phillips Precision Medicraft (PPM) unveils a next-generation model for tailored\, end-to-end production solutions. By dedicating customer-specific manufacturing cells\, equipment\, and resources—acting as a seamless extension of OEM operations\, PPM boosts speed and throughput while cutting costs and eliminating the need for lead times. A global spine OEM study\, where dedicated cells for plates\, cages\, and screws drove significant capacity gains via automation and robotics—delivered increased volume and cost reductions through dedicated resources. The model rests on three pillars: \n1. Dedicated robotics cells and vertical processes to eliminate dependencies and waste. \n2. Agile automation\, forecasting\, and KPIs for rapid adaptation. \n3. Data-driven cultural frameworks enabling collaboration & team empowerment for sustained innovation. \nKey Outcomes: summary of replicable strategies\, measurable improvements in production\, lead times\, and cost savings. \nAttend this session by Phillips Precision Medicraft in Booth 517.
URL:https://omtecexpo.com/session/dedicated-cellular-manufacturing-next-generation-end-to-end-manufacturing/
ATTACH;FMTTYPE=image/jpeg:https://omtecexpo.com/wp-content/uploads/2026/03/modern-manufacturing-floor.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260611T090000
DTEND;TZID=UTC:20260611T094500
DTSTAMP:20260603T225056
CREATED:20260212T133906Z
LAST-MODIFIED:20260528T174709Z
UID:10000071-1781168400-1781171100@omtecexpo.com
SUMMARY:The Innovative Tech Behind the OMTEC Award-Winning Companies
DESCRIPTION:Hear directly from this year’s OMTEC Excellence Award recipients as they take you behind the scenes of their technology journeys — from early concept to successful commercialization. The panelists will share the challenges they faced\, the pivotal design and development decisions they made\, and the key lessons learned in bringing groundbreaking technologies to market. \n\nStryker is being recognized for the development of Triathlon Gold femoral knee\, the company’s most recent innovation in 3D printed implants. Triathlon Gold\, which is an option for patients with metal sensitivity or bone cement allergy concerns\, combines the company’s Triathlon CR design with an additively manufactured titanium substrate and biocompatible titanium nitride coating.\n\n\nTHINK Surgical is reshaping the joint replacement market with the TMINI System\, an implant-agnostic robot that is compatible with nine FDA cleared implant vendor partners. Enabling technology is a key segment that’s driving future growth in orthopedics and THINK Surgical is at the forefront of the evolution.\n\n\nCarlsmed combines personalized surgical planning with 3D-printed spinal implants. The company’s aprevo technology has two FDA Breakthrough Device Designations and is supported by CMS reimbursement pathways. Carlsmed is being recognized for advancing personalized spine surgery\, a unique movement in the space.
URL:https://omtecexpo.com/session/the-innovative-tech-behind-the-omtec-award-winning-companies/
ATTACH;FMTTYPE=image/png:https://omtecexpo.com/wp-content/uploads/2026/02/OMTEC-Award-Winners.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260611T090000
DTEND;TZID=UTC:20260611T094500
DTSTAMP:20260603T225056
CREATED:20260219T141445Z
LAST-MODIFIED:20260224T200256Z
UID:10000084-1781168400-1781171100@omtecexpo.com
SUMMARY:From Non-Sterile to Sterile Packaging: A Real-World Case Study
DESCRIPTION:Transitioning from non-sterile to sterile packaging is a significant leap for orthopedic device companies\, but one that many have taken or considered due to industry forces\, such as the mounting regulatory expectations in Europe under MDR and operational pressures in the U.S. as procedures shift from hospitals to ASCs. This case study presents OrthoPediatric’s journey through that transformation\, illustrating both the strategic vision and the technical challenges behind bringing sterile-packaged pediatric orthopedic devices to market. Through a partnership with Packaging Compliance Labs\, an external packaging expert\, the team consolidated 1\,300 SKUs into 7 standardized pouches; developed packaging that could accommodate a wide range of implant sizes using the same pouch and carton; and finalized a new validation and materials strategy. The outcome was a sterile packaging system that not only meets global safety and compliance expectations but also delivers measurable operational and commercial benefits while being scalable to additional systems. \nSession speakers represent OrthoPediatrics and Packaging Compliance Labs. \nKey Takeaways\n1. Recognize industry drivers behind the orthopedic sector’s shift from non-sterile to sterile packaging and their impact on global strategies.\n2. Apply practical lessons from a real-world transition\, including SKU consolidation\, design flexibility\, and worst-case validation planning.\n3. Understand the business impact of inventory optimization and SPD efficiency in meeting growing market and hospital demands for sterile offerings.
URL:https://omtecexpo.com/session/from-non-sterile-to-sterile-packaging-a-real-world-case-study/
ATTACH;FMTTYPE=image/jpeg:https://omtecexpo.com/wp-content/uploads/2026/02/Packaging-Boxes.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260611T101500
DTEND;TZID=UTC:20260611T110000
DTSTAMP:20260603T225056
CREATED:20260212T161337Z
LAST-MODIFIED:20260526T201906Z
UID:10000074-1781172900-1781175600@omtecexpo.com
SUMMARY:Important Trends Shaping the Future of Additive Manufacturing
DESCRIPTION:Additive manufacturing and 3D printing are becoming strategic drivers of innovation in orthopedic implant development. From patient-specific implants and porous structures that promote osseointegration to use of resorbable polymers and bioprinted scaffolds to supply chain resilience and faster product iteration\, the technology is reshaping how implants are designed\, validated and manufactured. \nThis session will explore where AM/3D printing is headed next\, including advances in materials\, automation\, quality assurance and regulatory pathways\, and what OEMs must consider to scale production responsibly. Industry experts will share real-world applications and discuss how the technology will influence cost structures\, design freedom and competitive differentiation over the next decade. \nSession speakers represent ATEC Spine\, Zimmer Biomet\, ADDUp and Brinter. \nKey Takeaways\n1. Learn how leaders in the space are handling quality\, repeatability and scalability of implants with AM.\n2. Understand design and production advances shaping AM in orthopedics.\n2. Gain insight into the materials\, systems and players driving innovation in the space.
URL:https://omtecexpo.com/session/important-trends-shaping-the-future-of-additive-manufacturing/
ATTACH;FMTTYPE=image/jpeg:https://omtecexpo.com/wp-content/uploads/2025/03/Amnovis-Unlocking-Cost-Efficiency-in-3D-Printed-Implants.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260611T101500
DTEND;TZID=UTC:20260611T110000
DTSTAMP:20260603T225056
CREATED:20260403T152006Z
LAST-MODIFIED:20260403T153659Z
UID:10000098-1781172900-1781175600@omtecexpo.com
SUMMARY:Leverage Outsourced Partners for Faster\, Smarter Product Development
DESCRIPTION:Orthopedic OEMs are increasingly turning to outsourced partners to accelerate innovation\, access specialized expertise\, and manage costs more effectively. From early-stage design and prototyping to testing\, regulatory support\, and manufacturing scale-up\, the right partners can extend internal capabilities and reduce time to market. Selecting collaborators with proven technical depth\, quality systems\, and a track record of successful commercialization is critical to maintaining a competitive edge. \nAttendees of this session will hear presentations from three contract manufacturers that offer design and manufacturing expertise. \nAccelerate Launches & Minimize Costs: Manufacturer of Record & Kitting\nAvalign Technologies\, Inc.  \nFor OEMs who manage multiple projects with limited internal resources\, outsourcing can help balance workloads and allow internal teams to focus on strategic priorities. A reliable CDMO partner can function as an extension of your organization\, enabling OEMs to commercialize more programs without adding internal resources.  \nWhen serving as the Manufacturer of Record (MoR)\, Avalign Technologies assumes responsibility for design\, development\, and regulatory compliance\, utilizing customer design inputs. Combined with outsourced kitting\, this approach can reduce duplicate inspections\, improve working capital efficiency\, enable more projects\, and relieve constrained engineering and operations resources.  \nAttendees will learn practical ROI considerations and lessons from real programs. As a trusted CDMO\, Avalign can manufacture\, source\, kit\, and hold complete instrument sets\, enabling inventory flexibility and a scalable one-stop supplier model that supports faster\, more predictable launches.   \nMicrobiology as a Competitive Advantage in Accelerating MedTech\nEXALTA  \nMicrobiology sits at the intersection of patient safety\, regulatory rigor\, and time-to-market. As FDA expectations evolve and EU MDR requirements intensify\, the way that microbiology is integrated into product development directly shapes launch timelines\, regulatory confidence\, and commercialization outcomes.  \nThis session explores how treating microbiology as an integrated development discipline — embedded alongside product development\, regulatory\, and manufacturing — can materially accelerate medtech programs without compromising safety or compliance. David Hannah\, Group Chief Technology Officer will share how in-house microbiology expertise\, supported by ISO 17025-accredited capabilities and real-world MDR manufacturing experience\, enables earlier insight\, tighter development loops\, and stronger regulatory readiness\, helping medical device companies bring breakthrough innovations to market on compressed\, more predictable timelines.  \nBridging Prototype to Production with Fast\, Flexible Manufacturing\nLifestyle Medical – Manufacturing Division  \nMedical device teams must move fast without compromising quality. Whether supporting early innovators or established OEMs launching line extensions\, the challenge is the same: deliver human-use devices quickly and correctly.  \nThis presentation outlines a manufacturing model built to bridge the gap between prototyping and high-volume production. Lifestyle Medical Manufacturing delivers two-week lead times\, efficient small-batch builds\, and early Design for Manufacturability collaboration to maintain momentum through pilot\, clinical\, and early commercialization phases. By avoiding oversized commitments and long queues\, teams can build tens to hundreds of units at full medical quality standards. With dedicated capacity\, streamlined workflows\, and experienced machinists\, speed and quality coexist. The result: fewer surprises\, fewer deviations\, and devices built right the first time. 
URL:https://omtecexpo.com/session/leverage-outsourced-partners-for-faster-smarter-product-development/
ATTACH;FMTTYPE=image/jpeg:https://omtecexpo.com/wp-content/uploads/2026/04/orthopedic-product-development.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260611T101500
DTEND;TZID=UTC:20260611T110000
DTSTAMP:20260603T225056
CREATED:20260404T162615Z
LAST-MODIFIED:20260519T011728Z
UID:10000099-1781172900-1781175600@omtecexpo.com
SUMMARY:Embracing Successful Nearshoring Strategies
DESCRIPTION:Global supply chains continue to face disruption\, prompting orthopedic companies to evaluate not only where they manufacture\, but how their overall manufacturing footprint is designed. While nearshoring and onshoring are often tactical responses to risk\, leading organizations are also taking a more strategic approach by reassessing their global manufacturing networks for resilience\, efficiency\, and scale. This informative and interactive session explores how to strategically approach manufacturing footprint decisions\, including consolidation\, capacity alignment\, and network simplification. Speakers will share practical perspectives on how to turn footprint strategy into a competitive advantage and how to identify the triggers that consolidation may be the right next move. \nPartners from Plante Moran will speak during this session. \nKey Takeaways \n\nGain insight into how orthopedic companies are evolving manufacturing footprints to drive competitive advantage.\nIdentify the signals that indicate consolidation may be the right next move.\nUnderstand the tradeoffs\, cost considerations\, and execution challenges of manufacturing footprint decisions.
URL:https://omtecexpo.com/session/embracing-successful-onshoring-strategies/
ATTACH;FMTTYPE=image/jpeg:https://omtecexpo.com/wp-content/uploads/2026/04/global-supply-chain-map.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260611T110000
DTEND;TZID=UTC:20260611T111500
DTSTAMP:20260603T225056
CREATED:20260318T120347Z
LAST-MODIFIED:20260318T122854Z
UID:10000095-1781175600-1781176500@omtecexpo.com
SUMMARY:Magnesium: An Absorbable Nutrient Metal Whose Time has Come
DESCRIPTION:A century ago\, magnesium (Mg) was first used for fracture fixation. Despite its promise as an absorbable material\, inconsistent material purity led to unpredictable outcomes\, and the field pivoted toward permanent metals. Today\, the “leave nothing behind” philosophy\, combined with advanced metallurgy\, has renewed interest in Mg as an absorbable implant material. \nModern Mg alloys offer 10x the stiffness of absorbable polymers\, providing functional performance comparable to titanium while eliminating the long-term risks of permanent hardware or removal surgeries. This presentation explores Fort Wayne Metals’ ZXM100\, a high-purity nutrient alloy (Mg-Zn-Ca-Mn). We will detail its mechanical properties\, degradation profiles\, and available forms in precision bar and wire. Attendees will gain insight into the unique design considerations necessary to successfully integrate Mg into next-generation orthopedic devices. \nAttend this session by Fort Wayne Metals in Booth 725.
URL:https://omtecexpo.com/session/magnesium-an-absorbable-nutrient-metal-whose-time-has-come/
ATTACH;FMTTYPE=image/jpeg:https://omtecexpo.com/wp-content/uploads/2026/03/magnesium-materials.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260611T112000
DTEND;TZID=UTC:20260611T113500
DTSTAMP:20260603T225056
CREATED:20260318T120341Z
LAST-MODIFIED:20260318T122836Z
UID:10000096-1781176800-1781177700@omtecexpo.com
SUMMARY:How Early Machining Decisions Reduce Risk\, Cost\, and Delays
DESCRIPTION:Even small design decisions in medical device development can significantly impact manufacturing cost\, lead time\, quality\, and regulatory risk. Too often\, OEMs uncover manufacturability challenges late in the process\, when design changes are most disruptive and expensive. This session is about how early collaboration between OEMs and precision manufacturers\, combined with design for manufacturability (DFM) principles\, can reduce iterations\, prevent tolerance stack-ups\, and smooth the transition from prototype to production. The presentation will highlight common DFM pitfalls in small\, complex medical components\, including over-specified tolerances\, material selection challenges\, and inspection limitations. Attendees will learn best practices for engaging manufacturing partners earlier\, reducing scrap\, improving time to market\, and maintaining quality and compliance\, ultimately lowering total cost of ownership and program risk.  \nAttend this session by Criterion Precision Machining in Booth 956.
URL:https://omtecexpo.com/session/how-early-machining-decisions-reduce-risk-cost-and-delays/
ATTACH;FMTTYPE=image/jpeg:https://omtecexpo.com/wp-content/uploads/2026/03/decision-making-process.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260611T114000
DTEND;TZID=UTC:20260611T115500
DTSTAMP:20260603T225056
CREATED:20260318T120315Z
LAST-MODIFIED:20260318T122811Z
UID:10000097-1781178000-1781178900@omtecexpo.com
SUMMARY:The Power of Two: Expanding FDA-designated Nanotechnology in Implants
DESCRIPTION:In our 2025 OMTEC presentation\, Nanovis highlighted the defining features of our FDA-designated nanotechnology\, nanoVIS Ti\, including how nanoscale surface properties influence biological response\, our Four Pillars of Healing framework\, partner adoption\, and how we streamline customer integration from development through commercialization. We concluded by referencing additional nanotechnologies in development.   \nAt OMTEC 2026\, Nanovis will officially launch a new nanotechnology and show how our platform is expanding beyond a single surface solution. The presentation will compare key features of the new surface to nanoVIS Ti; explain how the Four Pillars of Healing apply; and outline regulatory progress and early partnership opportunities\, including the ability to be among the first to commercialize this technology. With this launch\, Nanovis will become the only company offering two FDA-designated nanotechnologies for implant surfaces.  \nAttend this session by Nanovis in Booth 746.
URL:https://omtecexpo.com/session/the-power-of-two-expanding-fda-designated-nanotechnology-in-implants/
ATTACH;FMTTYPE=image/jpeg:https://omtecexpo.com/wp-content/uploads/2026/03/nanotechnology-in-orthopedics.jpg
END:VEVENT
END:VCALENDAR